{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:12:13Z","timestamp":1793686333160,"version":"4.5.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007949","name":"Reumatikerf\u00f6rbundet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["09150172110053"],"award-info":[{"award-number":["09150172110053"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ard.2025.11.023","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T11:53:00Z","timestamp":1766663580000},"page":"425-434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inflammation rather than anticitrullinated protein antibodies is associated with cardiovascular mortality in RA: insights from rheumatoid arthritis and coronary artery disease cohorts"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8246-7055","authenticated-orcid":false,"given":"Veerle F.A.M.","family":"Derksen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Lindschou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Winkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela E.","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma C.","family":"de Moel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom W.J.","family":"Huizinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"M\u00e4rz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janus C.","family":"Jakobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette H.M.","family":"van der Helm - Van Mil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 E.M.","family":"Toes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Ajeganova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Leipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8121-5879","authenticated-orcid":false,"given":"Diane","family":"van der Woude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ard.2025.11.023_bib0001","doi-asserted-by":"crossref","first-page":"k1036","DOI":"10.1136\/bmj.k1036","article-title":"Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications","volume":"361","author":"England","year":"2018","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ard.2025.11.023_bib0002","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S2665-9913(20)30221-6","article-title":"Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout","volume":"3","author":"Hansildaar","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"6","key":"10.1016\/j.ard.2025.11.023_bib0003","article-title":"Comparison of cardiovascular outcomes in patients with and without rheumatoid arthritis: a meta-analysis of observational studies","volume":"15","author":"Barkhane","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.ard.2025.11.023_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102925","article-title":"Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus","volume":"21","author":"Restivo","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.ard.2025.11.023_bib0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/annrheumdis-2017-211735","article-title":"Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis","volume":"77","author":"Crowson","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2025.11.023_bib0006","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13075-016-1177-9","article-title":"Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study","volume":"18","author":"van Wesemael","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.ard.2025.11.023_bib0007","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/rheumatology\/keq266","article-title":"Obesity in rheumatoid arthritis","volume":"50","author":"Stavropoulos-Kalinoglou","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.ard.2025.11.023_bib0008","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41584-023-00969-7","article-title":"Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease","volume":"19","author":"Weber","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ard.2025.11.023_bib0009","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.atherosclerosis.2018.07.014","article-title":"Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions","volume":"276","author":"Raggi","year":"2018","journal-title":"Atherosclerosis"},{"issue":"7855","key":"10.1016\/j.ard.2025.11.023_bib0010","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ard.2025.11.023_bib0011","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41584-022-00786-4","article-title":"From risk to chronicity: evolution of autoreactive B cell and antibody responses in rheumatoid arthritis","volume":"18","author":"Scherer","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"10.1016\/j.ard.2025.11.023_bib0012","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2006.051391","article-title":"Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review","volume":"65","author":"Avouac","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.ard.2025.11.023_bib0013","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/art.24622","article-title":"Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways","volume":"60","author":"Trouw","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.ard.2025.11.023_bib0014","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/ard.2010.142091","article-title":"Fc\u03b3 receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteins","volume":"70","author":"Laurent","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.ard.2025.11.023_bib0015","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1136\/annrheumdis-2015-208579","article-title":"Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts","volume":"75","author":"Ajeganova","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.ard.2025.11.023_bib0016","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/art.24390","article-title":"Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis","volume":"61","author":"L\u00f3pez-Longo","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.ard.2025.11.023_bib0017","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/acr.22296","article-title":"Mortality trends in patients with early rheumatoid arthritis over 20 years: results from the Norfolk Arthritis Register","volume":"66","author":"Humphreys","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"10.1016\/j.ard.2025.11.023_bib0018","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/art.41381","article-title":"Anti-citrullinated protein antibody specificities, rheumatoid factor isotypes, and incident cardiovascular events in patients with rheumatoid arthritis","volume":"72","author":"Westerlind","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.ard.2025.11.023_bib0019","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/art.39198","article-title":"Rheumatoid arthritis, anti-cyclic citrullinated peptide positivity, and cardiovascular disease risk in the women\u2019s health initiative","volume":"67","author":"Mackey","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.ard.2025.11.023_bib0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/acr.24071","article-title":"Association of seropositivity and mortality in rheumatoid arthritis and the impact of treatment with disease-modifying antirheumatic drugs: results from a real-world study","volume":"72","author":"Alemao","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.ard.2025.11.023_bib0021","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/ard-2023-224814","article-title":"Long-term mortality in treated-to-target RA and UA: results of the BeSt and IMPROVED cohort","volume":"83","author":"Heckert","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.ard.2025.11.023_bib0022","first-page":"768","article-title":"The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis","volume":"56","author":"Barra","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.ard.2025.11.023_bib0023","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3899\/jrheum.160670","article-title":"Anticyclic citrullinated peptide antibodies and rheumatoid factor as risk factors for 10-year cardiovascular morbidity in patients with rheumatoid arthritis: a Large Inception Cohort Study","volume":"44","author":"Berendsen","year":"2017","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.ard.2025.11.023_bib0024","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/art.37961","article-title":"Brief report: citrullination within the atherosclerotic plaque: a potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis","volume":"65","author":"Sokolove","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ard.2025.11.023_bib0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13075-015-0665-7","article-title":"Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis","volume":"17","author":"Habets","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.ard.2025.11.023_bib0026","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.atherosclerosis.2013.02.009","article-title":"Antibodies to citrullinated peptides and risk of coronary heart disease","volume":"228","author":"Cambridge","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ard.2025.11.023_bib0027","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcard.2017.04.046","article-title":"Long-term mortality in patients with ST-segment elevation myocardial infarction is associated with anti-citrullinated protein antibodies","volume":"240","author":"Hermans","year":"2017","journal-title":"Int J Cardiol"},{"issue":"10","key":"10.1016\/j.ard.2025.11.023_bib0028","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nm1637","article-title":"Protein carbamylation links inflammation, smoking, uremia and atherogenesis","volume":"13","author":"Wang","year":"2007","journal-title":"Nat Med"},{"issue":"1 suppl 1","key":"10.1016\/j.ard.2025.11.023_bib0029","first-page":"S1","article-title":"Rationale and design of the LURIC study\u2013a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease","volume":"2","author":"Winkelmann","year":"2001","journal-title":"Pharmacogenomics"},{"issue":"5 suppl 31","key":"10.1016\/j.ard.2025.11.023_bib0030","first-page":"S100","article-title":"The Leiden early arthritis clinic","volume":"21","author":"van Aken","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.ard.2025.11.023_bib0031","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/rheumatology\/39.9.1031","article-title":"Remission and response to early treatment of RA assessed by the Disease Activity Score. BARFOT study group. Better anti-rheumatic farmacotherapy","volume":"39","author":"Svensson","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ard.2025.11.023_bib0032","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ijcard.2015.01.020","article-title":"Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial","volume":"182","author":"Winkel","year":"2015","journal-title":"Int J Cardiol"},{"issue":"16","key":"10.1016\/j.ard.2025.11.023_bib0033","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1200\/JCO.2009.25.0654","article-title":"Basic concepts and methods for joint models of longitudinal and survival data","volume":"28","author":"Ibrahim","year":"2010","journal-title":"J Clin Oncol"},{"issue":"26","key":"10.1016\/j.ard.2025.11.023_bib0034","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1002\/sim.7838","article-title":"Exploring causality mechanism in the joint analysis of longitudinal and survival data","volume":"37","author":"Liu","year":"2018","journal-title":"Stat Med"},{"issue":"14","key":"10.1016\/j.ard.2025.11.023_bib0035","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1080\/02664763.2021.1962260","article-title":"Causal mediation analysis between resistance exercise and reduced risk of cardiovascular disease based on the Aerobics Center Longitudinal Study","volume":"49","author":"Huang","year":"2022","journal-title":"J Appl Stat"},{"issue":"11","key":"10.1016\/j.ard.2025.11.023_bib0036","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/art.40562","article-title":"Triple positivity for anti-citrullinated protein autoantibodies, rheumatoid factor, and anti-carbamylated protein antibodies conferring high specificity for rheumatoid arthritis: implications for very early identification of at-risk individuals","volume":"70","author":"Verheul","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.ard.2025.11.023_bib0037","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1136\/annrheumdis-2019-215843","article-title":"Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA","volume":"79","author":"Matthijssen","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ard.2025.11.023_bib0038","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/art.39098","article-title":"Disease activity in rheumatoid arthritis and the risk of cardiovascular events","volume":"67","author":"Solomon","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.ard.2025.11.023_bib0039","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/art.39267","article-title":"Risk factors for the rapid increase in risk of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case-control study","volume":"67","author":"Mantel","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.ard.2025.11.023_bib0040","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/annrheumdis-2013-204715","article-title":"The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis","volume":"73","author":"Zhang","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ard.2025.11.023_bib0041","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/annrheumdis-2013-204987","article-title":"Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration","volume":"75","author":"Navarro-Mill\u00e1n","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.ard.2025.11.023_bib0042","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/art.39502","article-title":"Association of triple therapy with improvement in cholesterol profiles over two-year followup in the treatment of early aggressive rheumatoid arthritis trial","volume":"68","author":"Charles-Schoeman","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.ard.2025.11.023_bib0043","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/annrheumdis-2013-204345","article-title":"Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study","volume":"74","author":"McInnes","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.ard.2025.11.023_bib0044","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/ard-2022-223302","article-title":"Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis","volume":"82","author":"Solomon","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2025.11.023_bib0045","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12891-017-1563-8","article-title":"Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients","volume":"18","author":"Spinelli","year":"2017","journal-title":"BMC Musculoskelet Disord"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672504590X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672504590X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T12:25:38Z","timestamp":1786191938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672504590X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S000349672504590X"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2025.11.023","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation rather than anticitrullinated protein antibodies is associated with cardiovascular mortality in RA: insights from rheumatoid arthritis and coronary artery disease cohorts","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2025.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}